Company
News and press
As a thought leader in the technology space, GATC Health is committed to remaining at the forefront of innovation. Here’s our latest happenings, updates, and industry recognition.
GATC Health Publishes a Multi-Omics Exosome Study Defining a New Therapeutic Path in Diabetes
Irvine, CA — May 11, 2026 — GATC Health is announcing the publication of “The Multi-Omics Profiling of Early-Passage Mesenchymal Stem …
GATC Health Publishes a Digital Twin Framework for Therapeutic Development
New paper formalizes the multi-scale architecture behind Operon™ and advances GATC’s position in AI-native drug development Irvine, CA — Ma…
Drug Discovery News Covers GATC’s PNAS Breakthrough, Extending Media Momentum Around GATC-1021
Recent coverage in Drug Discovery News reinforces continued external interest in GATC’s AI-enabled discovery platform and the therapeutic p…
GATC Health Senior Leadership Presents at Two Key Industry Forums Focused on AI, Capital Efficiency, and Addiction Innovation
GATC Health Senior Leadership Presents at Two Key Industry Forums Focused on AI, Capital Efficiency, and Addiction Innovation Recent partic…
GATC Health Focuses on Identifying Distinct ALS Subtypes With Answer ALS and the LADDIA Initiative
GATC Health Focuses on Identifying Distinct ALS Subtypes With Answer ALS and the LADDIA Initiative Irvine, CA — April 28, 2026 — We are inc…
GATC Health Scientists and Leadership Featured as Authors on Two New Peer-Reviewed Publications Advancing AI-Driven Drug Discovery and Systems Biology
GATC Health Scientists and Leadership Featured as Authors on Two New Peer-Reviewed Publications Advancing AI-Driven Drug Discovery and Syst…
GATC Health Receives Concentrated Media Visibility Across AI, Capital Markets and Regulatory Policy Conversations
Recent coverage in BioSpace and GEN highlights GATC’s growing relevance in industry discussions spanning AI adoption, biotech financing, de…
GATC Health and UC Irvine Announce Landmark PNAS Publication Validating AI-Platform for Opioid Use Disorder Treatment
IRVINE, Calif., April 07, 2026 (GLOBE NEWSWIRE) — GATC Health Corp, a leading tech-bio company leveraging artificial intelligence (AI…
Fierce Biotech: AI model designs new treatment candidate for opioid addiction that cuts cravings in rats
Fierce Biotech: AI model designs new treatment candidate for opioid addiction that cuts cravings in rats By Darren Incorvaia Apr 6, 2026 3…
